Ping An Ventures has led a US$10 million series A funding round in Prenetics, a Hong Kong-based DNA biotechnology firm, according to a company announcement. Other investors include Indonesia's Lippo Group-backed Venturra Capital, Capital Union Investments and existing investors 500 Startups and COENT Venture Partners. "We believe precision medicine is the future of healthcare…We are […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.